COSTS OF DRUG TREATMENT UNDER PRIVATE INSURANCE

私人保险下的戒毒治疗费用

• 批准号: 6175615
• 负责人: ROLAND STURM
• 金额: $ 18.67万
• 依托单位: RAND CORPORATION
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-05-01 至 2002-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6175615
• 关键词: alcoholism /alcohol abuse therapy; behavioral /social science research tag; drug abuse therapy; health care cost /financing; health care facility information system; health care model; health care policy; health care quality; health care service availability; health care service evaluation; health care service utilization; health economics; health insurance; health related legal; health services research tag; human data; managed care; mental health services

DESCRIPTION: Applicant's Abstract Care for drug or alcohol abuse is usually excluded or limited in insurance or employer mandates and parity legislation. One reason is uncertainty about the cost impact of such policies for substance abuse treatment, especially under the changes in the health care environment. To fill this informational gap, this project will study drug and alcohol abuse benefits, access to care, utilization, and costs under managed care, track changes over time, and simulate the consequences of enacting legislation for substance abuse that parallels the variety of parity efforts in mental health under way at the state level. Its specific aims are: 1. Develop a data base of employer contracts with managed behavioral health care organizations regarding substance abuse care. Collect administrative data on enrollees, access, and claims, and structure them for quantitative analyses. Track changes in benefits related to substance abuse problems, access to care, utilization, and costs over time. 2. Study access, intensity of care, and cost patterns for substance abuse care over time and under different insurance arrangements. 3. Identify the effects of specific benefit designs (limits, deductibles, copayments) on access, intensity of care, and cost, adapting economic models of health care demand. 4. Predict the implications of substance abuse parity using parameters currently discussed for mental health care, combining the detailed models based on administrative data with information from new national surveys to make nationally representative predictions. Particular attention will be paid to differences between employed policyholders, their adult dependents, and their child dependents.

描述：申请人摘要

项目成果

Substance abuse service utilization under managed care: HMOs versus carve-out plans.

管理式医疗下的药物滥用服务利用：HMO 与剥离计划。

• DOI: 10.1007/bf02287305
• 发表时间: 1999
• 期刊: The journal of behavioral health services & research
• 作者: Stein,B;Reardon,E;Sturm,R
• 通讯作者: Sturm,R

How expensive are unlimited substance abuse benefits under managed care?

管理式医疗下的无限药物滥用福利有多贵？

• DOI: 10.1007/bf02287491
• 发表时间: 1999
• 期刊: The journal of behavioral health services & research
• 作者: Sturm,R;Zhang,W;Schoenbaum,M
• 通讯作者: Schoenbaum,M

Managed care risk contracts and substance abuse treatment.

管理护理风险合同和药物滥用治疗。

• 发表时间: 2000
• 期刊: Inquiry : a journal of medical care organization, provision and financing.
• 作者: Sturm,R

Alcoholism treatment in managed private sector plans. How are carve-out arrangements affecting costs and utilization?

私营部门管理计划中的酗酒治疗。

• 发表时间: 2001
• 期刊: Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism.
• 作者: Sturm,R;Stein,B;Zhang,W;Stan,PJ
• 通讯作者: Stan,PJ